For businesses investing in technology, manufacturing, engineering, product development, and R&D, one of the most practical questions under Turkish industrial property law is whether an invention should be protected as a patent or as a utility model. In Türkiye, that choice is not merely technical. It affects filing strategy, examination depth, protection period, litigation posture, budget planning, and even the commercial value of the right in licensing or investment discussions. Official 2025 data published by TÜRKPATENT shows that domestic applicants filed 11,394 patent applications and 3,927 utility model applications in that year alone, which confirms that both routes remain actively used in practice.
The legal foundation for both rights is Law No. 6769 on Industrial Property, which entered into force on January 10, 2017. The Code expressly covers patents and utility models, along with applications, registrations, post-registration procedures, and enforcement-related mechanisms. TÜRKPATENT is the competent office for both forms of protection, and the current WIPO PCT Applicant’s Guide for Türkiye confirms that Turkish national protection is available not only for patents but also for utility models.
At first glance, patents and utility models may look similar because both protect inventions. But Turkish law separates them in important ways. A patent requires novelty, inventive step, and industrial applicability, while a utility model requires novelty and industrial applicability and has its own subject-matter exclusions and a different procedural route. The choice between the two should therefore be made strategically, not mechanically.
The legal framework in Turkey
Turkish industrial property law treats patents and utility models as parallel but distinct forms of protection. Law No. 6769 identifies both as industrial property rights and regulates them within the same code, but it places them in separate sections with different rules on protectability, grant procedure, invalidation, and term. The English reference text on WIPO Lex also makes clear that the Code is the central statute for these rights, although the Turkish original prevails if any interpretive conflict arises.
For international applicants, the Turkish framework is also connected to the PCT system. The current WIPO PCT Applicant’s Guide states that the types of national protection available via the PCT in Türkiye include patents, patents of addition, and utility models. That matters because a foreign applicant does not have to think about patent versus utility model only at the domestic-filing stage; the strategic choice can also arise when planning Turkish national-phase entry.
What a patent protects in Turkey
Under Article 82, a patent is granted for inventions in all fields of technology provided that the invention is new, involves an inventive step, and is susceptible to industry. The same article also lists subject matter that is not considered an invention as such, including discoveries, scientific theories, mathematical methods, business methods, computer programs as such, aesthetic creations, and presentations of information, and it excludes certain categories such as inventions contrary to public order or morality, certain biological processes, treatment and diagnosis methods for the human or animal body, and the mere discovery of parts of the human body.
That three-part test is the first major dividing line between patents and utility models in Turkey. The inventive step requirement makes patents the stronger but more demanding right. In practical terms, a patent is the better fit where the invention reflects a real technical leap rather than a commercially useful but relatively modest improvement. This is especially important in sectors where investors, licensees, or courts may closely examine technical merit.
What a utility model protects in Turkey
The Turkish utility model regime is narrower but still commercially important. Article 142 states that inventions that are new and industrially applicable may be protected by utility model. Notably, the article does not require inventive step in the same way Article 82 does for patents. That omission is one of the core reasons utility models remain attractive for incremental innovation, especially where the invention is practical and commercially valuable but may face challenges under a full inventive-step analysis.
At the same time, Turkish law excludes several categories from utility model protection. In addition to the exclusions already carried over from Article 82, Article 142 states that utility model protection is unavailable for inventions related to chemical and biological substances or methods, pharmaceutical-related substances or methods, biotechnological inventions, and inventions relating to products obtained by methods or those methods themselves. That means utility models are generally much more suitable for mechanical, structural, or device-oriented innovations than for pharma, biotech, chemistry, or process-heavy inventions.
This is a critical strategic point. If the invention is in a field such as formulations, drug-related technology, biotech, or process chemistry, the patent route is not merely preferable; it may be the only viable industrial property route under Law No. 6769. A utility model cannot be used as a shortcut around those exclusions.
The first big difference: inventive step
The clearest doctrinal difference between patents and utility models in Turkey is the inventive step requirement. Patents require novelty, inventive step, and industrial applicability under Article 82, while utility models under Article 142 require novelty and industrial applicability, without a separate inventive-step threshold in the text.
That legal difference has major commercial consequences. A company with a breakthrough engineering solution, a platform technology, or an invention expected to anchor licensing or investment value will often prefer a patent because the right is designed for higher-threshold innovation. By contrast, a company with an incremental but still market-relevant improvement may find the utility model more realistic. In practice, this tends to make utility models especially attractive for hardware refinements, practical product improvements, and SME-led innovation, while patents remain the stronger choice where technical distinctiveness is central to the business case. This is an inference from the statutory requirements, not a formal label used by the Office.
The second big difference: examination path
Patents and utility models also differ significantly in prosecution. For patents, the Code requires a search report and then a separate examination request. Article 96 states that the applicant must request a search, paying the fee, within twelve months from the application date, or the application is deemed withdrawn. Article 98 then states that the applicant must request substantive examination within three months from notification of the examination report, otherwise the application is considered withdrawn. If the application and invention comply with the Code, the Office decides to grant the patent and publishes it in the Bulletin.
Utility models follow a different route under Article 143. The applicant must request a search either with the application or, after formal-consistency notification, within two months under the regulatory structure reflected in the article. The search report is then issued and published, the applicant may object to its contents within three months, and third parties may also present opinions. After considering the search report, any appeal, and any third-party opinions, the Office may grant the utility model, require amendments, or reject the application.
This procedural contrast is one reason utility models are often seen as a more accessible route for simpler inventions. Patent prosecution is more layered because it moves through search, publication, examination, and then possible post-grant opposition. Utility model prosecution is still formal and structured, but it does not replicate the full patent examination-plus-opposition sequence.
Publication and early-stage effects
Both patent and utility model applications are published after eighteen months from the application or priority date under Article 97, unless earlier publication occurs in the circumstances described by the Code. Article 97 also states that the applicant receives temporary protection from publication, and third parties may present comments on the patentability of the invention once the patent application is published, although they do not become parties at that phase.
For strategy, this means both routes can create early leverage, but they do so differently. Publication can matter for negotiations, competitor signaling, and eventual enforcement planning. A business deciding between patent and utility model should therefore think not only about final grant, but also about how much value it expects to derive from the application phase itself.
The third big difference: post-grant challenge
One of the most important practical distinctions lies in post-grant opposition. Under Article 99, third parties may object to a granted patent within six months from publication of the decision granting the patent in the Bulletin. The grounds include lack of patentability under Articles 82 and 83, insufficient disclosure, and extension beyond the initial application. If no valid objection is filed, the grant becomes final; if an objection is filed, the patentee may respond and the Board may maintain the patent, maintain it in amended form, or declare it null.
Utility models do not follow the same post-grant opposition model. Article 143 expressly states that after the utility model is granted, the appeal procedure in Article 99 cannot operate and only invalidation from the court may be requested. That is a major procedural difference. Patents face a structured administrative post-grant challenge. Utility models do not; they move directly into a court-based invalidation framework after grant.
From a strategic perspective, this cuts both ways. For a right holder, the lack of Article 99 post-grant opposition can simplify the administrative path for utility models. For a competitor or defendant, however, the challenge route shifts more quickly into court. For a high-value invention expected to face immediate attacks, the patent route may provide a more structured administrative testing phase before litigation. For a business that wants a more direct grant route and is prepared to defend validity in court if needed, the utility model may still be attractive.
The fourth big difference: term of protection
The protection period is another decisive difference. Under Article 101, patent protection lasts twenty years from the application date, while utility model protection lasts ten years from the application date, and neither period can be extended.
That term difference alone often determines the filing strategy. If the invention is expected to have a long commercial life, support long-term licensing, or protect a technology platform that will remain valuable over many years, the patent route has a clear structural advantage. If the commercial lifecycle is shorter, or the invention is likely to become obsolete relatively quickly, a ten-year utility model may be commercially sufficient.
The fee schedules also reinforce this distinction. TÜRKPATENT’s 2026 Patent Fees page lists annual renewal fees from the 3rd through the 20th year, while the 2026 Utility Fees page lists renewal fees from the 2nd through the 10th year. This means the long-term maintenance burden differs materially between the two rights.
The fifth big difference: subject-matter reach
The patent route is broader in technological scope. A patent may cover inventions in all fields of technology so long as the Article 82 requirements are met and the statutory exclusions do not apply. By contrast, the utility model route is expressly unavailable for chemical and biological substances or methods, pharmaceutical-related inventions, biotechnological inventions, and method-related product categories described in Article 142.
This means the patent-versus-utility-model choice is not always a free strategic preference. In some cases, the law effectively decides the question. If the invention sits in pharma, biotech, chemistry, or process-dominant technology, a utility model is usually not a legally available substitute. On the other hand, if the invention concerns a mechanical improvement, a practical apparatus, a structural product refinement, or a device-level innovation, both routes may be open and the strategy question becomes more nuanced.
Conversion between patent and utility model
Turkish law also offers flexibility through conversion. Under Article 104, a patent applicant may request that a pending patent application be transformed into a utility model application. Conversely, a utility model applicant may request transformation into a patent application, at the latest by the end of the three-month period following notification of the search report. The same article states that the same priority right is recognized for the transformed application if priority was already claimed, and that retransformation is not admitted.
This conversion mechanism is strategically valuable. It allows applicants to correct course when the initial filing choice proves suboptimal. A patent applicant facing concerns about inventive step may decide that a utility model offers a more realistic protection route. A utility model applicant whose invention appears strong enough for fuller patent treatment may choose to move upward into the patent regime, provided the timing conditions are met.
In commercial practice, conversion can reduce early filing pressure. A company does not always need perfect certainty at day one, but it does need to understand the timing limits. Once those windows close, the flexibility narrows sharply.
Costs and filing economics
While the law defines the rights, TÜRKPATENT’s fee schedules illustrate their practical economics. The 2026 official fee pages show that patents carry a broader set of fees linked to search, examination, conversion, annual maintenance, and international or European-patent-related processes, including PCT national-phase entry. Utility model fees include application, certificate issuance, conversion, search-report fees, renewal fees, and a specific national phase entry fee as a utility model under the PCT.
This does not justify a universal statement that utility models are always “cheap patents,” because the commercial picture depends on the case. But the official fee structure does show that the two routes differ in ongoing cost shape, procedural steps, and term-related maintenance exposure. For startups, SMEs, and budget-sensitive R&D teams, that difference can be important.
Which route is better for enforcement?
There is no single answer. A patent is generally the stronger right where the invention is technically robust, expected to remain valuable for many years, or likely to sit at the center of licensing or investment discussions. The inventive-step threshold and twenty-year term can make a patent more attractive for long-horizon strategies. The six-month post-grant opposition system also means a granted patent may emerge from a more formalized challenge process before later litigation.
A utility model, however, can still be highly useful where speed, practicality, and commercial sufficiency matter more than maximal term length. Because it does not require inventive step in the same way and is designed for new, industrially applicable inventions within a narrower field, it may be the better route for incremental engineering improvements, short-to-medium product lifecycles, and markets where early enforceable positioning matters more than twenty-year exclusivity. That is a strategic inference from Articles 142–143 and Article 101.
When a patent usually makes more sense
A patent will usually be the better choice in Turkey when the invention is likely to clear an inventive-step analysis and the business expects long-term value. That is especially true in sectors where technology differentiation is deep, the invention may be licensed internationally, or investors will scrutinize the strength of the IP position. It is also the right answer where the invention falls into subject matter that utility models cannot cover, such as pharma-related inventions, biotech, chemistry, or certain process-heavy technologies.
A patent also makes strategic sense where the company expects significant future enforcement or portfolio transactions. The combination of broader subject-matter reach, twenty-year term, and formal examination can make patents more suitable for core technologies than for short-lived commercial improvements.
When a utility model usually makes more sense
A utility model will often make more sense where the invention is commercially useful but may not comfortably support a patent-level inventive-step case. It is also attractive where the technology is mechanical or structural, the commercial lifecycle is shorter, or the company wants a more streamlined route without the patent opposition structure in Article 99.
This can be particularly relevant for SMEs, local manufacturers, hardware developers, and businesses iterating practical product improvements rather than building deep platform technologies. A ten-year right can be more than enough where the product cycle is fast and the improvement is likely to be overtaken by later iterations before a twenty-year patent term would ever be fully exploited. That is again a strategic inference from the law and fee structure, rather than an official slogan.
Final thoughts
The real lesson from Turkish law is that patent vs utility model is not a question of stronger versus weaker in the abstract. It is a question of fit. A patent fits inventions that are new, industrially applicable, and genuinely inventive, especially where subject matter, term length, and long-term commercial value justify the fuller route. A utility model fits inventions that are new and industrially applicable within a narrower technological field, especially where the innovation is practical, incremental, and commercially useful but does not need or cannot support the full patent pathway.
In Turkey, the smartest filing strategy often begins by asking four questions. Does the invention likely satisfy inventive step? Does it fall into a field excluded from utility model protection? How long is the commercial lifecycle likely to be? And is the business better served by a longer, more examination-intensive right or by a narrower but potentially more accessible route? Turkish law, TÜRKPATENT’s current fee schedules, and the PCT framework all support making that choice deliberately rather than by habit.
Yanıt yok